Srinagar, April 07, 2014 (PPI-OT): In occupied Kashmir, the authorities have admitted the sale of dozens of new substandard drug samples including the largely-consumed Paracetamol and Diazepam in the territory. A report prepared by the Deputy Secretary to Health and Medical Education department noted that 76 new drug samples have been found to be substandard.
The report has been prepared after the involvement of officials in the spurious drug scam came to fore earlier in the Public Interest Litigation (PIL) filed by President of the Doctors Association Kashmir (DAK), Dr Nisar-ul-Hassan, through advocate Butt Fayaz.
The report reveals that Paracetamol manufactured by Pharose Remedies Limited, Bari Brahmana, Jammu, has failed in the dissolution test. The official documents reveal that the drug had failed in the test.
As per the report, Diazepam tablets with batch no T809 manufactured by Biotech Pharma, 64, Phase III, Gangyal Jammu, has been found to be not of standard quality. “Most of the tablets in each strip were found to be in broken condition and few tablets were found to be not sufficiently hard to withstand handling with crumbling,” the report notes.
The report has further mentioned that some injections have also failed in the particulate matter test. Officials said there is a possibility that the injections may contain dust particles and might have also caused deaths.
For more information, contact:
Kashmir Media Service
Phone: 92-51-4435548, 4435549